Literature DB >> 28104240

Serum and follicular fluid monocyte chemotactic protein-1 levels are elevated in obese women and are associated with poorer clinical pregnancy rate after in vitro fertilization: a pilot study.

Erkan Buyuk1, Obehi A Asemota2, Zaher Merhi3, Maureen J Charron4, Dara S Berger5, Athena Zapantis6, Sangita K Jindal2.   

Abstract

OBJECTIVE: To determine whether monocyte chemotactic protein-1 (MCP-1), a proinflammatory chemokine important in ovulation, is abnormally elevated in obese women undergoing IVF and whether serum and follicular fluid (FF) levels of MCP-1 are associated with IVF outcome.
DESIGN: Prospective pilot study.
SETTING: Academic center. PATIENT(S): Women undergoing IVF. INTERVENTION(S): Serum and FF were collected from women undergoing IVF. MAIN OUTCOME MEASURE(S): Correlation between MCP-1 and other inflammatory markers with adiposity and pregnancy outcome after IVF. RESULT(S): Obese women had significantly higher serum and FF MCP-1 levels compared with overweight and normal weight women. Serum MCP-1, granulocyte colony stimulating factor, catalase, and C-reactive protein (CRP) were positively correlated with body mass index (BMI). After adjusting for age and baseline FSH, these correlations remained significant for serum MCP-1, granulocyte colony stimulating factor, and CRP. In the FF, only MCP-1 was positively correlated with BMI. Women who became pregnant had significantly lower serum MCP-1 and CRP levels compared with those who did not become pregnant; this difference was more pronounced among women with diminished ovarian reserve. Receiver operating characteristic curve demonstrated that serum MCP-1 levels >373.0 pg/mL in all women and >362.6pg/mL in women with diminished ovarian reserve predicted failure to achieve a clinical pregnancy. CONCLUSION(S): Elevations in serum and FF MCP-1 levels are positively correlated with adiposity and negatively correlated with pregnancy rates (PRs) in women undergoing IVF.
Copyright © 2017 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IVF; MCP-1; Obesity; follicular fluid; ovary

Mesh:

Substances:

Year:  2017        PMID: 28104240     DOI: 10.1016/j.fertnstert.2016.12.023

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  New models of lipopolysaccharide-induced implantation loss reveal insights into the inflammatory response.

Authors:  Sarah Moustafa; Dana N Joseph; Robert N Taylor; Shannon Whirledge
Journal:  Am J Reprod Immunol       Date:  2019-01-28       Impact factor: 3.886

2.  Psychological aspects of infertility. A systematic review.

Authors:  Filip Szkodziak; Jarosław Krzyżanowski; Piotr Szkodziak
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

Review 3.  Role of Inflammaging on the Reproductive Function and Pregnancy.

Authors:  Alice Zavatta; Francesca Parisi; Chiara Mandò; Chiara Scaccabarozzi; Valeria M Savasi; Irene Cetin
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-15       Impact factor: 8.667

4.  Chemokine profile in women with moderate to severe anxiety and depression during pregnancy.

Authors:  Ignacio Camacho-Arroyo; Mónica Flores-Ramos; Ismael Mancilla-Herrera; Fausto Moisés Coronel Cruz; Joselin Hernández-Ruiz; Gabriela Pellón Diaz; Blanca Farfán Labonne; María Del Pilar Meza-Rodríguez; Philippe Leff Gelman
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-04       Impact factor: 3.007

Review 5.  Role of hormonal and inflammatory alterations in obesity-related reproductive dysfunction at the level of the hypothalamic-pituitary-ovarian axis.

Authors:  Michelle Goldsammler; Zaher Merhi; Erkan Buyuk
Journal:  Reprod Biol Endocrinol       Date:  2018-05-09       Impact factor: 5.211

6.  Elevated Levels of Monocyte Chemotactic Protein-1 in the Follicular Fluid Reveals Different Populations among Women with Severe Endometriosis.

Authors:  Pierre-Emmanuel Bouet; Juan-Manuel Chao de la Barca; Lisa Boucret; Philippe Descamps; Guillaume Legendre; Hady El Hachem; Simon Blanchard; Pascale Jeannin; Pascal Reynier; Pascale May-Panloup
Journal:  J Clin Med       Date:  2020-05-01       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.